Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
SNDK
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$21.2B
| $693K | ﹤0.01% |
+2,600
| New | +$438K |
|
2477
KORU Medical Systems
KRMD
$146M
| $693K | ﹤0.01% |
164,900
+119,000
| +259% | +$488K |
|
2478
SelectQuote
SLQT
$94.5M
| $692K | ﹤0.01% |
823,271
-197,968
| -19% | -$180K |
|
2479
Paysafe
PSFE
$340M
| $692K | ﹤0.01% |
92,594
+22,400
| +32% | +$175K |
|
|
NFGC
2480
New Found Gold
NFGC
$688M
| $686K | ﹤0.01% |
445,400
-260,923
| -37% | -$500K |
|
|
NIU
2481
Niu Technologies
NIU
$149M
| $683K | ﹤0.01% |
340,000
+20,000
| +6% | +$52.9K |
|
2482
Cogent Communications
CCOI
$494M
| $683K | ﹤0.01% |
49,231
-17,900
| -27% | -$330K |
|
2483
iShares US Home Construction ETF
ITB
$2.2B
| $683K | ﹤0.01% |
+6,537
| New | +$620K |
|
2484
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$325M
| $682K | ﹤0.01% |
+18,360
| New | +$777K |
|
2485
British American Tobacco
BTI
$119B
| $679K | ﹤0.01% |
10,999
-570,300
| -98% | -$34.4M |
|
2486
Westrock Coffee
WEST
$766M
| $679K | ﹤0.01% |
83,700
+41,700
| +99% | +$299K |
|
2487
RxSight
RXST
$268M
| $678K | ﹤0.01% |
140,693
+80,293
| +133% | +$485K |
|
2488
Transcat
TRNS
$784M
| $678K | ﹤0.01% |
7,305
-27,395
| -79% | -$2.24M |
|
2489
Pure Cycle
PCYO
$267M
| $678K | ﹤0.01% |
63,265
-21,174
| -25% | -$232K |
|
2490
Vulcan Materials
VMC
$33.5B
| $674K | ﹤0.01% |
2,285
-168,320
| -99% | -$48.2M |
|
|
GENB
2491
Generate Biomedicines
GENB
$2.04B
| $669K | ﹤0.01% |
+39,685
| New | +$541K |
|
2492
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.67B
| $669K | ﹤0.01% |
+2,000
| New | +$573K |
|
|
COE
2493
51Talk Online Education Group
COE
$84.6M
| $665K | ﹤0.01% |
41,675
-2,600
| -6% | -$60.5K |
|
2494
Natural Alternatives International
NAII
$12.4M
| $663K | ﹤0.01% |
277,457
-13,899
| -5% | -$36.3K |
|
|
EEX
2495
DELISTED
Emerald Holding
EEX
| $661K | ﹤0.01% |
131,063
-36,900
| -22% | -$179K |
|
|
MH
2496
McGraw Hill
MH
$2.44B
| $660K | ﹤0.01% |
69,659
-99,441
| -59% | -$1.2M |
|
2497
vTv Therapeutics
VTVT
$130M
| $657K | ﹤0.01% |
+17,454
| New | +$605K |
|
|
ALMS
2498
Alumis Inc
ALMS
$1.37B
| $657K | ﹤0.01% |
23,335
-51,832
| -69% | -$1.21M |
|
2499
SOPHiA GENETICS
SOPH
$712M
| $654K | ﹤0.01% |
113,300
+53,500
| +89% | +$271K |
|
2500
Entera Bio
ENTX
$521M
| $653K | ﹤0.01% |
368,847
-104,595
| -22% | -$131K |
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.